Atrial fibrillation, the most common type of irregular heart rhythm, is estimated to affect more than 12 million U.S. adults by 2030. To improve care for the heart condition, the AHA and Bristol Myers Squibb-Pfizer alliance are rolling out an AFib initiative in phases. The latest phase focuses on pharmacists, “an important but underrepresented voice in AFib care,” the AHA said April 23.
The initiative, which runs through June 2025, will host pharmacists in a roundtable event to find gaps and opportunities in AFib care. The findings will then be shared with thousands of hospitals and outpatient clinics in the U.S.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
